Stellon Biotech Inc.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Stellon Biotech Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Stellon Biotech Inc.

Stellon Biotech Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by TACROLIMUS. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: prophylaxis organ, transplant see, clinical studies, tacrolimus capsules, rejection adult, pediatric patients, receiving allogeneic, astellas pharma. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
TACROLIMUS 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Stellon Biotech Inc.

Brand nameGenericTypeRoute
Tacrolimus TACROLIMUS HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products does Stellon Biotech Inc. make?
1 FDA drug label records name Stellon Biotech Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Stellon Biotech Inc. produce?
The most frequent active ingredients in this portfolio are TACROLIMUS.

Are Stellon Biotech Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.